Allozen Pharma Private Limited
About Allozen Pharma Private Limited
Data last updated:
Allozen Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 16 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2019PTC128784. Its GSTIN is 29AASCA8302Q1ZU (Karnataka). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹45 Lakh. It is led by directors Prafful Jain and Atish Ashok Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹125.84 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Cr (net margin 0.8%) and EBITDA of ₹5.18 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 73% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹29.4 Cr and satisfied charges of ₹25 Cr on record. Court records list 17 cases involving the company, including 17 filed by the company; 15 cases are pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo 49/3 Khata No 191 Sreegandhada Kaval Sunkadakate Yeshwantapura Hobli Magadi, Road, Bangalore, Karnataka, India – 560091
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Allozen Pharma Private Limited
The main business activity of Allozen Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Allozen Pharma Private Limited
Allozen Pharma Private Limited is audited by CHETNA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHETNA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Allozen Pharma Private Limited
Allozen Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prafful Jain Also directs: Nexamed Global Private Limited | Director | 16 Oct 2019 | 6 Years 11 Months | Current |
| Atish Ashok Jain Also directs: Pasolite Electricals Private Limited | Director | 01 Oct 2022 | 4 Years 0 Months | Current |
Financials of Allozen Pharma Private Limited FY 2024 filings available
Allozen Pharma Private Limited reported revenue of ₹125.84 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Allozen Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 73% over five years, including 10% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Allozen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.18 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.04 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Allozen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Allozen Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Allozen Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Allozen Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2024 | Hdfc Bank Limited | ₹20.01 Lakh | Open |
| 30 Jun 2022 | The Hongkong and Shanghai Banking Corporation Limited | ₹14 Cr | Open |
| 30 Jun 2022 | The Hongkong and Shanghai Banking Corporation Limited | ₹20 Lakh | Open |
| 27 Feb 2020 | Others | ₹15 Cr | Open |
| 01 Feb 2025 | Others | ₹25 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Allozen Pharma Private Limited
Allozen Pharma Private Limited has a workforce of 26 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Allozen Pharma Private Limited
Allozen Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AASCA8302Q1ZU | Karnataka | Active | 05 Dec 2019 |
| 07AASCA8302Q1Z0 | Delhi | Active | 08 Nov 2019 |
| 08AASCA8302Q1ZY | Rajasthan | Active | 21 Nov 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Allozen Pharma Private Limited
Allozen Pharma Private Limited has 17 court cases on record: 17 filed by Allozen Pharma. 15 cases are pending and 2 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 0 | 14 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against Sri. Anjanadri Enterprises | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against Lifeline Pharmaceutical | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against S G Enterprises | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against Mahi Pharma and Surgical | Pending |
Full case history
All 17 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Allozen Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Allozen Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Allozen Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Allozen Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Allozen Pharma Private Limited
Frequently Asked Questions about Allozen Pharma Private Limited
Allozen Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 16 October 2019 (7+ years old) and is registered under CIN U24290KA2019PTC128784.
Allozen Pharma reported revenue of ₹125.84 Cr for FY 2025 (up 10% YoY).
Allozen Pharma has 2 current directors:
- Prafful Jain - Director
- Atish Ashok Jain - Director
Allozen Pharma reported a net profit of ₹1.04 Cr (net margin 0.8%) and EBITDA of ₹5.18 Cr (EBITDA margin 4.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Allozen Pharma is 27% over three years and 73% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Allozen Pharma is 29AASCA8302Q1ZU, registered in Karnataka. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 07AASCA8302Q1Z0 (Delhi), 08AASCA8302Q1ZY (Rajasthan).
The CIN (Corporate Identification Number) of Allozen Pharma is U24290KA2019PTC128784. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allozen Pharma has 17 court cases on record: 17 filed by the company. 15 are pending. Most are in the district courts.
Allozen Pharma was incorporated on 16 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.